Status:
COMPLETED
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Anemia
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This study will assess the efficacy and safety of intravenous Mircera, given as maintenance treatment for renal anemia in chronic kidney disease patients on dialysis who were previously receiving iv e...
Eligibility Criteria
Inclusion
- adult patients \>=18 years of age;
- chronic renal anemia;
- on dialysis therapy for at least 12 weeks before screening;
- receiving IV epoetin for at least 8 weeks before screening.
Exclusion
- women who are pregnant, breastfeeding or using unreliable birth control methods;
- administration of another investigational drug within 4 weeks before screening, or during the study period.
Key Trial Info
Start Date :
February 1 2004
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2005
Estimated Enrollment :
673 Patients enrolled
Trial Details
Trial ID
NCT00077610
Start Date
February 1 2004
End Date
August 1 2005
Last Update
January 13 2017
Active Locations (99)
Enter a location and click search to find clinical trials sorted by distance.
1
Birmingham, Alabama, United States, 35211
2
Mobile, Alabama, United States, 36608
3
Montgomery, Alabama, United States, 36106
4
Encino, California, United States, 91356